Anti-interleukin-5 therapy for asthma and hypereosinophilic syndrome.
摘要：
Interleukin 5 (IL-5) is a key cytokine in the regulation of eosinophilia and eosinophil activation in humans. Monoclonal antibodies to anti–IL-5 have become available for use in clinical studies in humans. This article discusses the rationale for the use of anti–IL-5 therapy in asthma and hypereosinophilic syndrome and summarizes the available clinical data on the use of anti–IL-5 to treat these disorders.
展开
DOI：
10.1016/j.iac.2004.06.007
被引量：
年份：
2004
通过文献互助平台发起求助，成功后即可免费获取论文全文。
请先登入
相似文献
参考文献
引证文献
辅助模式
0
引用
文献可以批量引用啦~
欢迎点我试用！
